Kaken Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -25.82% vs 32.97% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -91.70% vs 87.53% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "18,261.00",
          "val2": "24,618.00",
          "chgp": "-25.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,189.00",
          "val2": "6,462.00",
          "chgp": "-81.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "11.00",
          "val2": "7.00",
          "chgp": "57.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "28.00",
          "val2": "531.00",
          "chgp": "-94.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "406.00",
          "val2": "4,889.00",
          "chgp": "-91.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.30%",
          "val2": "237.30%",
          "chgp": "-21.80%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 30.52% vs -1.29% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 73.77% vs 47.52% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "94,035.00",
          "val2": "72,044.00",
          "chgp": "30.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "23,590.00",
          "val2": "12,267.00",
          "chgp": "92.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "28.00",
          "val2": "17.00",
          "chgp": "64.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2,025.00",
          "val2": "-19.00",
          "chgp": "-10,557.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "13,945.00",
          "val2": "8,025.00",
          "chgp": "73.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "223.70%",
          "val2": "132.10%",
          "chgp": "9.16%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

18,261.00

24,618.00

-25.82%

Operating Profit (PBDIT) excl Other Income

1,189.00

6,462.00

-81.60%

Interest

11.00

7.00

57.14%

Exceptional Items

28.00

531.00

-94.73%

Consolidate Net Profit

406.00

4,889.00

-91.70%

Operating Profit Margin (Excl OI)

19.30%

237.30%

-21.80%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is -25.82% vs 32.97% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is -91.70% vs 87.53% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

94,035.00

72,044.00

30.52%

Operating Profit (PBDIT) excl Other Income

23,590.00

12,267.00

92.30%

Interest

28.00

17.00

64.71%

Exceptional Items

-2,025.00

-19.00

-10,557.89%

Consolidate Net Profit

13,945.00

8,025.00

73.77%

Operating Profit Margin (Excl OI)

223.70%

132.10%

9.16%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 30.52% vs -1.29% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 73.77% vs 47.52% in Mar 2024

All Annual Results